Literature DB >> 7010905

Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.

T Lauritzen, C Binder, O K Faber.   

Abstract

The interaction between variation in insulin absorption and beta-cell function was studied as well as the possible relation between subcutaneous blood flow through the region of injection and the variability in insulin absorption. The results indicate that the dose of insulin, the type of insulin preparation and the local blood flow influence the insulin absorption. Residual endogenous insulin secretion, governed by the blood glucose values, serves as a modulator.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7010905     DOI: 10.1111/j.1651-2227.1980.tb15323.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  12 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Subcutaneous degradation of insulin.

Authors:  R W Stevenson
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

3.  U100 insulin and insulin absorption.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

4.  Influence of heat on insulin absorption: different effects on amorphous and soluble insulins.

Authors:  V A Koivisto
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

5.  Smoking and insulin absorption.

Authors:  G Williams; J Pickup
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

6.  Subcutaneous degradation of insulin.

Authors:  T Deckert; B Hansen; T Lauritzen; J S Christiansen
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

Review 7.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 8.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

9.  Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes.

Authors:  B Linde; R Gunnarsson
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

10.  Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients.

Authors:  G Williams; J C Pickup; S Bowcock; E Cooke; H Keen
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.